Evaluation of an IFN-gamma assay in the diagnosis of latent tuberculosis in patients with psoriasis in a highly endemic setting

Acta Dermato-Venereologica

Volumn 91, Issue 6, 2011, Pages 694-697

  de Andrade Lima, Emerson ^a   de Andrade Lima, Mariana ^a   de Lorena, Virgínia M Barros ^b   de Miranda Gomes, Yara ^b   Lupi, Omar ^c   Benard, Gil ^d  

^a Psoriasis Out patient Service   (Brazil)

^b Osvaldo Cruz Foundation ecife   (Brazil)

^c FEDERAL UNIVERSITY OF THE STATE OF RIO DE JANEIRO   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Elispot; Interferon ; Latent tuberculosis infection; Psoriasis; References; Release assay; Tnf; Tuberculin skin test

Indexed keywords

ADULT; ARTICLE; BRAZIL; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; INTERFERON GAMMA RELEASE ASSAY; INTERMETHOD COMPARISON; LATENT TUBERCULOSIS; MALE; PRIORITY JOURNAL; PSORIASIS; SKIN INDURATION; TUBERCULIN TEST;

ADULT; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BRAZIL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INTERFERON-GAMMA; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PSORIASIS; TUBERCULIN TEST; YOUNG ADULT;

EID: 80055022400     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-1151     Document Type: Article

References (29)

1. Lin J, Ziring D, Desai S, Kim S, Wong M, Korin Y, et al. TNF-alpha blockade in human diseases: an overview of efficacy and safety. Clin Immunol 2008; 126: 13-30.
2. Sichletidis L, Settas L, Spyratos D, Chloros D, Patakas D. Tuberculosis in patients receiving anti-TNF agents despite chemoprophylaxis. Int J Tuberc Lung Dis 2006; 10: 1127-1132.
3. 3. Al-Orainey IO. Diagnosis of latent tuberculosis: can we do better? Ann Thoracic Med 2009; l/4: 5-9.
4. Andersen P, Munk ME, Pollok JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. Lancet 2000; 23: 1099-1104.
5. Lalvani A. Spotting latent infection: the path to better tuberculosis control. Thorax 2003; 58: 916-918.
6. Pai M, Kalantri S, Menzies D. Discordance between tuberculin skin test and interferon-γ assays. Int J Tuberc Lung Dis 2006; 10: 942-943.
7. Mahomed H, Hughes EJ, Hawkridge T, Minnies D, Simon E, Little F, et al. Comparison of Mantoux skin test with three generations of a whole blood IFN-gamma assay for tuberculosis infection. Int J Tuberc Lung Dis 2006; 10: 310-316.
8. Hill PC, Brookes RH, Fox A, Fielding K, Jeffries DJ, Jackson-Sillah D, et al. Large scale evaluation of enzymelinked immunospot assay and skin test for diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in the Gambia. Clin Inf Dis 2004; 38: 966-973.
9. Pai M, Gokhale K, Joshi R, Dogra S, Kalantri S, Mendiratta DK, et al. Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon γ assay with tuberculin skin testing. JAMA 2005; 293: 2746-2755.
10. Brazilian Society of Pneumology. III Brazilian consensus on TB. J Bras Pneumol 2009; 35: 1018-1048.
11. Silva LCR, Silveira GG, Arnone M, Romiti R, Geluk A, Franken KCLM, et al. Decrease in Mycobacterium tuberculosis specific immune responses in patients with untreated psoriasis living in a tuberculosis endemic area. Arch Dermatol Res 2010; 302: 255-262.
12. Souza TNL. Evaluation of the prevalence of Mycobacterium tuberculosis infection in São Paulo. (Thesis). Department of Infectious Diseases, Medical School of the University of São Paulo, 1999.
13. Ewer K, Deeks J, Alvarez L, Bryant G, Waller S, Andersen P, et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003; 361: 1168-1173.
14. Ferrara G, Losi M. D'Amico R, Poversi P, Piro R, Meacci M, et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 2006; 367: 1328.
15. Kang YA, Lee HW, Yoon HI, Cho B, Han SK, Shim YS, et al. Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosisburden country. JAMA 2005; 293: 2756-2761.
16. Hill PC, Jackson-Sillah DJ, Fox A, Brookes RH, de Jong BC, Lugos MD, et al. Incidence of tuberculosis and the predictive value of ELISPOT and Mantoux tests in Gambian case contacts. PLoS One 2008; 3: e1379.
17. Tsiouri G, Gaitanis G, Kiorpelidou D, Dionysiou A, Efthymiou A, Daskalopoulos, et al. Tuberculosis skin test overestimates tuberculosis hypersensitivity in adult patients with psoriasis. Dermatology 2009; 219: 119-125.
18. Krueger GG, Hill HR, Jederberg WW. Inflammatory and immune cell function in psoriasis - a subtle disorder I. In vivo and in vitro survey. J Invest Dermatol 1978; 71: 189-194.
19. Lindholm L, Magnusson BL, Mobacken H. Depressed nonspecific lymphocyte reactivity in psoriasis. Arch Dermatol Res. 1978; 263: 121-125.
20. Kapp A, Gillitzer R, Kirchner H, Schopf E, Decreased production of interferon in whole blood cultures derived from patients with psoriasis. J Invest Dermatol 1988; 90: 511-514.
21. Dogan B, Harmanyeri Y. Intradermal antigen tests and the Koebner phenomenon in psoriasis. Int J Dermatol 1997; 36: 263-265.
22. Hill PC, Brookes RH, Fox A, Jackson-Sillah D, Lugos MD, Jeffries DJ, Donkor SA, et al. Surprisingly high specificity of the PPD skin test for M. tuberculosis infection from recent exposure in The Gambia. PLoS One 2006; 1: e68.
23. Ponce de Leon D, Acevedo-Vasquez E, Sanchez-Torres A, Cucho M, Alfaro J, Perich R, et al. Attenuated response to purified protein derivative in patients with rheumatoid arthritis: study in a population with a high prevalence of tuberculosis. Ann Rheum Dis 2005; 64: 1360-1365.
24. Ponce de Leon D, Acevedo-Vasquez E, Alvizuri S, Gutierrez C, Cucho M, Alfaro J, et al. Comparison of an interferongamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population. J Rheumatol 2008; 35: 776-781.
25. Marques CD, Duarte AL, de Lorena VM, Souza JR, Souza WV, de Miranda Gomes Y, et al. Evaluation of an interferon gamma assay in the diagnosis of latent tuberculosis infection in patients with rheumatoid arthritis. Rheumatol Int 2009; 30: 57-62.
26. Sellam J, Hamdi H, Roy C, Baron G, Lemann M, Puéchal X, et al. Comparison of in vitro-specific blood tests with tuberculin skin test for diagnosis of latent tuberculosis before anti-TNF therapy. Ann Rheum Dis 2007; 66: 1610-1615.
27. Murakami S, Takeno M, Kirino Y, Kobayashi M, Watanabe R, Kudo M, Ihata A et al. Screening of tuberculosis by interferon-gamma assay before biologic therapy for rheumatoid arthritis. Tuberculosis 2009; 89: 139-141.
28. Mow WS, Abreu-Martin MT, Papadakis KA, Pitchon He, Targan Sr, Vasiliauskas EA. High incidence of anergy in inflammatory bowel disease patients limits the usefulness of PPD screening before infliximab therapy. Clin Gastroenterol Hepatol 2004; 2: 309-313.
29. Laffitte E, Janssens JP, Roux-Lombard P, Thielen AM, Barde C, Marazza G, et al. Tuberculosis screening in patients with psoriasis before antitumour necrosis factor therapy: comparison of an interferon-γ release assay vs. tuberculin skin test. Br J Dermatol 2009; 161: 797-800.